Indiana Attorney General Todd Rokita is accusing Eli Lilly of conspiring with its competitors to artifically raise the price ...

Researchers in Indianapolis are launching a first-of-its-kind study when it comes to GLP-1 drugs and the impact on the ...

Pharmaceutical companies are paying thousands of Indiana doctors to talk about GLP-1 drugs, a WRTV Investigation has ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

Attorney General Todd Rokita is intensifying his efforts to lower insulin prices and improve healthcare affordability for ...

Rokita says Eli Lilly was part of a scheme that inflated insulin prices over the past decade by more than 1000%, despite low ...

The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...

Indiana Attorney General Todd Rokita has filed a lawsuit against Eli Lilly and Company to lower insulin prices, his office ...

Attorney General Todd Rokita said the lawsuit, filed last Wednesday in the Lake County Superior Court, is part of his ...

Indiana Attorney General Todd Rokita on Monday announced a new lawsuit against Indianapolis-based drug maker Eli Lilly and Co. The attorney general contends this suit, as well as previous litigation ...

The state accuses the pharmaceutical giant of colluding with other insulin makers to hike the price by more than 1,000% over ...

Indiana Attorney General Todd Rokita is taking legal action against Eli Lilly and Company to lower insulin prices and improve ...